Ä¢¹½ÊÓƵAPP

Paul Biondi is a Managing Partner at Ä¢¹½ÊÓƵAPP, leading Flagship’s product and partnering capabilities, including Pioneering Medicines, Partnering, and Pipeline and Product Innovation.

In this role, Paul oversees Pioneering Medicines, Flagship's in-house drug discovery and development unit, as well as therapeutic partnering and business development efforts for the Flagship ecosystem, including driving broad institution-wide Innovation Supply Chain partnerships with biopharma companies to jointly conceive and create innovative products.

Paul also works with Flagship company CEOs and their teams to achieve the best attainable value for each company, guiding them in their pipeline strategy, product concepts, R&D execution, and partnering approach. He serves on the boards of Flagship-founded companies, including Tessera Technologies (NASDAQ: TSRA) and Valo Health.

Paul joined Flagship following a seventeen-year tenure at Bristol-Myers Squibb (BMS). He served as the Senior Vice President of Strategy and Business Development, where he had enterprise-wide responsibility for establishing and evolving BMS’s strategy, and for pursuing strategic transactions to access external innovation, enhance BMS’s capabilities, and strengthen the company’s portfolio. Prior to this role, Paul held a series of leadership roles within BMS’ R&D organization, overseeing strategy, portfolio, and project management, and clinical and business operations. Paul previously spent nine years at Mercer Management Consulting.

Paul received his MBA from the J.L. Kellogg School of Management at Northwestern University and his B.A. from Dartmouth College.